Amikacin clinical studies

Revision as of 01:08, 31 December 2013 by Gerald Chi (talk | contribs) (Created page with "__NOTOC__ {{Amikacin}} {{CMG}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AMIKACIN SULFATE INJECTION [TEVA PARENTERAL MEDICINES, INC.] | ur...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Amikacin
AMIKACIN SULFATE® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


[1]

References

  1. ↑ "AMIKACIN SULFATE INJECTION [TEVA PARENTERAL MEDICINES, INC.]".

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Amikacin_clinical_studies&oldid=921637"